Clinical characteristics of occult findings after RRSO
| Patient Number | Age at RRSO (years) | Occult finding | BRCA gene involved | Type of pathogenic variant | FIGO STAGE | Cytology | Treatment | Vital status |
|---|---|---|---|---|---|---|---|---|
| 1 | 53 | STIC | BRCA1 | deletion exons 4–9 | STIC | NEG | Surgery | NED |
| 2 | 69 | STIC | BRCA1 | c.3018_3021delTTCA | STIC | NEG | Surgery | NED |
| 3 | 64 | STIC | negative/high risk | STIC | NEG | Surgery | NED | |
| 4 | 45 | STIC | BRCA1 | deletion exons 4–9 | (Staging NEG) procedure I C | PC | Surgery+ACT | NED |
| 5 | 56 | HGSC | BRCA1 | c.181T>G | III B | PC | Surgery+ACT | DOOD |
| 6 | 39 | HGSC | BRCA1 | c.5266dup.C | III B | PC | Surgery+ACT | OT |
| 7 | 57 | HGSC | BRCA1 | c.5266dup.C | I C | PC | Surgery+ACT | NED |
| 8 | 39 | HGSC | BRCA1 | c.1687C>T | III A | PC | Surgery+ACT | NED |
| 9 | 61 | HGSC | BRCA1 | deletion exons 4–9 | III A | PC | Surgery+ACT | OT |